the fourth time. Then he lost in the final of the Denmark Open and semifinal of the French Open, and triumphed again in the Hong Kong Open. Lee won a record fourth Masters Finals title, the season ending Super Series tournament. 2014 In January, Lee lost in the final of Korea Open to Chen Long, his fourth straight defeat by the Chinese. He recorded his tenth Malaysia Open title a week later. Soon after the triumph, he announced it would be his last Malaysia Open outing, as he would assess his condition after the Asian Games and might retire if the results were not good. However, his form improved and he won his third All England Open and India Open titles, although he was beaten by Simon Santoso in final of the Singapore Open. In the Thomas Cup, Lee won every match he played. Malaysia reached the finals, but lost to Japan with a score of 3–2. In June, he won the Japan Open for the third consecutive year and fifth time overall. He then lost in the semifinals of the Indonesia Open, ending his hopes of nine straight Super Series finals. Due to a serious hamstring injury, Lee withdrew from the 2014 Commonwealth Games in July, also ending his hopes of being the first men's singles shuttler to win 3 back-to-back gold medals at the games. Lee resumed play in August where he finished second for the third time at the World Championships, losing to Chen Long of China in straight sets. He again lost to Chen in the semifinals of Asian Games team competition, and to Lin Dan in the semifinals of the singles event a few days later. Doping In October 2014, local media reported that the Badminton Association of Malaysia confirmed that one of the nation's top shuttlers tested positive for dexamethasone after urine samples were taken during the World Championships in late August. The identity of the shuttler was not revealed but was widely believed to be Lee Chong Wei. Dexamethasone is not a performance-enhancing drug but a commonly administered anti-inflammatory corticosteroid that is not illegal when used off-season for injury rehabilitation, but deemed illegal if discovered in an athlete's body during competition. On 5 November 2014, Lee flew to Norway to witness the testing of his "B" sample at the Oslo University Hospital after the "A" sample had already tested positive in October. The